Literature DB >> 10899644

On hypothetical bias and calibration in cost-benefit studies.

B Liljas1, K Blumenschein.   

Abstract

Despite a sound foundation in economic welfare theory, willingness to pay (WTP) has not been used as a measure of benefits in economic evaluations of health and health care to the same extent as in other fields. Some have suggested that this is due to non-economists' reluctance to placing dollar values on the benefits of health care. However, another potential reason could be uncertainties about the validity of the WTP measure. In this paper, we outline the bias problems with the WTP method, and specifically focus on hypothetical bias; i.e. whether the WTP from hypothetical elicitation methods overstates the real WTP or not. This is done by examining the literature in this field, with emphasis on economic experiments where there is a greater possibility for comparison. The findings are that hypothetical WTP in general significantly overestimates real WTP, but that calibration methods to reduce or eliminate this difference are currently being developed. We conclude that while the area is still very much under development, there seem to be reasons to view the use of cost-benefit analysis as a reasonable alternative to the more common cost-effectiveness analysis.

Entities:  

Mesh:

Year:  2000        PMID: 10899644     DOI: 10.1016/s0168-8510(00)00067-1

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  6 in total

Review 1.  On individual preferences and aggregation in economic evaluation in healthcare.

Authors:  B Liljas; B Lindgren
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  The measurement of contingent valuation for health economics.

Authors:  Ahmed M Bayoumi
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

Authors:  David K Whynes; Emma J Frew; Jane L Wolstenholme
Journal:  Int J Health Care Finance Econ       Date:  2005-12

4.  Willingness to pay for adverse drug event regulatory actions.

Authors:  Jacoline Bouvy; Just Weemers; Huub Schellekens; Marc Koopmanschap
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 5.  The impact of economic evaluation on quality management in spine surgery.

Authors:  Norbert Boos
Journal:  Eur Spine J       Date:  2009-04-01       Impact factor: 3.134

6.  Willingness to give amid pandemics: a contingent valuation of anticipated nongovernmental immunization programs.

Authors:  William F Vásquez; Jennifer M Trudeau
Journal:  Int J Health Econ Manag       Date:  2021-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.